Well, just review the Chairmans Blogs which have itemized their plan for the remainder of the year. If you look back at the list they are executing on this plan. Nothing indicated they won't continue to execute. GC bonus structure spells out their confidence in hitting certain milestones even though I believe the FDA milestones are difficult to predict and hit in a specific timeframe. If they miss by a few weeks there I do not care. GC specifically stated they are launching Lympro in a couple of weeks. Take a look at slides 13, 19, 30, and 31 from recent investor presentation at LD Micro. Again, milestones spelled out.

Yes, my posts are positive, because I believe the company is about to have some fireworks and execute their plan. I am very busy, so I make comments but rarely attach links etc from my phone. I have done my due diligence for this stock.

It's Dec 5th. People check out for holidays on Dec 19th which leaves 2 weeks where AMBS will have a really captive market audience. I am quite certain there will be significant news within that timeframe. That's why I say next week it starts. I believe I commented to a couple of people here in private messages last month to not be surprised if the news doesn't start right at the beginning of Dec. I think AMBS is waiting to hear from the FDA about ODD for RP. Once that is in the bag then I think they will unleash Lympro data+++.